Global Injectable Benzodiazepine Market Size, Trends & Growth Opportunity, By Time of Action (Ultra-Short Acting, Short Acting, and Long Acting), By End User (Hospital and Clinic), By Application (Anxiety Disorders, Insomnia, Seizers, Alcohol Withdrawal, and Others), By Region and Forecast till 2027.

Global Injectable Benzodiazepine Market

The Global Injectable Benzodiazepine Market is expected to grow from US$ 268 Million in 2021 to US$ 456 Million by 2027; it is estimated to grow at a CAGR of 9.26% from 2022 to 2027.

Market Overview 

Benzodiazepine is a class of psychoactive medications used to treat insomnia, anxiety, seizures, panic attacks, and alcohol withdrawal. By increasing the effect of the neurotransmitter GABA, benzodiazepine creates a calming effect. In contrast to tablets and capsules, injectable benzodiazepine has a faster pharmacological effect.

Market Drivers

The rising prevalence of diseases such as anxiety disorders and panic disorders is anticipated to drive the global injectable benzodiazepine market development. Furthermore, an increase in public concern about preventive steps for stress-related conditions will benefit market growth. Furthermore, an increase in demand for these injectables is anticipated to drive the global injectable benzodiazepine market growth.

Market Restraints

However, misuse of benzodiazepine drugs is the challenging factor which is expected to hamper the global injectable benzodiazepine market growth.

Impact of Covid-19

COVID-19 is an unprecedented global public health emergency that has impacted almost every industry, with long-term impacts expected to impact industry development during the forecast period. Our ongoing study expands our research framework to include underlying COVID-19 issues and potential next steps. The study provides insights on COVID-19 by taking into account changes in consumer behaviour and demand, buying patterns, supply chain re-routing, the dynamics of current market forces, and major government interventions. The updated study offers insights, analysis, estimates, and forecasts based on the COVID-19 market impact.

Market Segmentation

Global Injectable Benzodiazepine Market is segmented into time of action such as Ultra-Short Acting, Short Acting, and Long Acting, by end user such as Hospital and Clinic. Further, market is segmented into Application such as Anxiety Disorders, Insomnia, Seizers, Alcohol Withdrawal, and Others.

Regional Analysis

Global Injectable Benzodiazepine Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

Market Key Players

Various key players are discussed in this report such as Eli Lilly and Company, Forest Laboratories, Inc., AstraZeneca plc, Pfizer, Inc., H. Lundbeck A/S, GlaxoSmithKline plc, Sanofi S.A., Johnson and Johnson, and Merck and Co., Inc.

Key Developments

• In January 2020, Xellia Hospital Sales Force inked a deal with Eton to promote Biorphen in institutions that favour ready-to-use injectable formulations.

• In October 2019, KemPharm's APADAZ (to treat ADHD) was licenced to KVK-Tech, Inc., who will make its generic AG-APADAZ available throughout the United States.

• Hikma Pharmaceuticals introduced clobazam oral suspension and tablets in December 2018, the generic equivalent to "Onfi" (marketed by H. Lundbeck A/S).

Market Taxonomy

By Time of Action
• Ultra-Short Acting
• Short Acting
• Long Acting

By End User
• Hospital 
• Clinic

By Application
• Anxiety Disorders
• Insomnia
• Seizers
• Alcohol Withdrawal
• Others

By Region
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa

Key Questions Addressed by the Report
• What are the Key Opportunities in Global Injectable Benzodiazepine Market?
• What will be the growth rate from 2022 to 2027?
• Which segment/region will have highest growth?
• What are the factors that will impact/drive the Market?
• What is the competitive Landscape in the Industry?
• What is the role of key players in the value chain?
• What are the strategies adopted by key players?

Global Injectable Benzodiazepine Market 
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Injectable Benzodiazepine Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Cumulative Impact due to recent Energy Crisis
4.2.5 Cumulative Impact due to nearing Economic Downturn
4.2.6 Post Covid-19 World Supply & Demand Conditions
4.2.7 Cumulative Impact of Russia-Ukraine Conflict
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Injectable Benzodiazepine Market, By Time of Action
5.1 Y-o-Y Growth Comparison, By Time of Action 
5.2 Global Injectable Benzodiazepine Market Share Analysis, By Time of Action 
5.3 Global Injectable Benzodiazepine Market Size and Forecast, By Time of Action
5.3.1Ultra-Short Acting
5.3.2 Short Acting
5.3.3Long Acting
6 Global Injectable Benzodiazepine Market, By End User
6.1 Y-o-Y Growth Comparison, By End User
6.2 Global Injectable Benzodiazepine Market Share Analysis, By End User
6.3 Global Injectable Benzodiazepine Market Size and Forecast, By End User
6.3.1 Hospital
6.3.2 Clinic
7 Global Injectable Benzodiazepine Market, By Application
7.1 Y-o-Y Growth Comparison, By Application
7.2 Global Injectable Benzodiazepine Market Share Analysis, By Application
7.3 Global Injectable Benzodiazepine Market Size and Forecast, By Application
7.3. 1 Anxiety Disorders
7.3.2  Insomnia
7.3.3 Seizers
7.3.4 Alcohol Withdrawal 
7.3.5 Others
8 Global Injectable Benzodiazepine Market, By Region
8.1 Global Injectable Benzodiazepine Market Share Analysis, By Region
8.2 Global Injectable Benzodiazepine Market Share Analysis, By Region
8.3 Global Injectable Benzodiazepine Market Size and Forecast, By Region
9 North America Injectable Benzodiazepine Market Analysis and Forecast (2022 – 2027)
9.1 Introduction
9.2 North America Injectable Benzodiazepine Market Share Analysis, By Time of Action
9.3 North America Injectable Benzodiazepine Market Size and Forecast, By End User
9.4 North America Injectable Benzodiazepine Market Size and Forecast, By Application
9.5 North America Injectable Benzodiazepine Market Size and Forecast, By Country
9.5.1 U.S.
9.5.2 Canada
9.5.3 Mexico
10 Europe Injectable Benzodiazepine Market Analysis and Forecast (2022 – 2027)
10.1 Introduction
10.2 Europe Injectable Benzodiazepine Market Share Analysis, By Time of Action 
10.3 Europe Injectable Benzodiazepine Market Size and Forecast, By End User 
10.4 Europe Injectable Benzodiazepine Market Size and Forecast, By Application
10.5 Europe Injectable Benzodiazepine Market Size and Forecast, By Country
10.5.1 Germany
10.5.2 France
10.5.3 UK
10.54. Rest of Europe
11 Asia Pacific Injectable Benzodiazepine Market Analysis and Forecast (2022 – 2027)
11.1 Introduction
11.2 Asia Pacific Injectable Benzodiazepine Market Share Analysis, By Time of Action 
11.3 Asia Pacific Injectable Benzodiazepine Market Size and Forecast, By End User 
11.4 Asia Pacific Injectable Benzodiazepine Market Size and Forecast, By Application
11.5 Asia Pacific Injectable Benzodiazepine Market Size and Forecast, By Country
11.5.1 China 
11.5.2 Japan
11.5.3 India
11.5.4. Rest of Asia Pacific
12 Latin America Injectable Benzodiazepine Market Analysis and Forecast (2022 – 2027)
12.1 Introduction
12.2 Latin America Injectable Benzodiazepine Market Share Analysis, By Time of Action 
12.3 Latin America Injectable Benzodiazepine Market Size and Forecast, By End User 
12.4 Latin America Injectable Benzodiazepine Market Size and Forecast, By Application
12.5 Latin America Injectable Benzodiazepine Market Size and Forecast, Country
13 Middle East Injectable Benzodiazepine Market Analysis and Forecast (2022 – 2027)
13.1 Introduction
13.2 Middle East Injectable Benzodiazepine Market Share Analysis, By Time of Action 
13.3 Middle East Injectable Benzodiazepine Market Size and Forecast, By End User 
13.4 Middle East Injectable Benzodiazepine Market Size and Forecast, By Application
13.5 Middle East Injectable Benzodiazepine Market Size and Forecast, By Country
14 Competitive Analysis
14.1 Competition Dashboard
14.2 Market share Analysis of Top Vendors
14.3 Key Development Strategies
15 Company Profiles
15.1 Eli Lilly and Company
15.1.1 Overview
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2 Forest Laboratories, Inc
15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3 AstraZeneca plc
15.3.1 Overview
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 Pfizer, Inc
15.4.1 Overview
15.4.2 Offerings
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 H. Lundbeck A/S
15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 GlaxoSmithKline plc
15.6.1 Overview
15.6.2 Offerings
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7 Sanofi S.A
15.7.1 Overview
15.7.2 Offerings
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies 
15.8 Johnson and Johnson
15.8.1 Overview
15.8.2 Offerings
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies 
15.9 Merck and Co., Inc
15.9.1 Overview
15.9.2 Offerings
15.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies